Utibron Neohaler
Active Ingredient(s): Indacaterol + GlycopyrrolateFDA Approved: * October 29, 2015
Pharm Company: * NOVARTIS PHARMS CORP
Category: Lungs (Pulmonary)
Indacaterol is an ultra-long-acting beta-adrenoceptor agonist[5] developed by Novartis. It needs to be taken only once a day,[6] unlike the related drugs formoterol and salmeterol. It is licensed only for the treatment of chronic obstructive pulmonary disease (COPD) (long-term data in patients with asthma are thus far lacking). It is delivered as an aerosol formulation through a dry powder inhaler. Medical uses A Cochrane review found benefit in lung functi... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.